when the men in this cohort were compared , each 1 mg/dl increment in baseline hdl-c ( mean 44.3 mg/dl ) was associated with a 5.5 % decrement in risk of `` '' definite '' '' chd death or myocardial infarction ( z = -5.4 ) , and each 1 mg/dl increase from baseline hdl-c levels ( mean increase = 1.6 mg/dl ) during the trial was associated with a 4.4 % risk reduction ( z = -2.2 ) .
C0018799
of
C0027051
myocardial infarcti